Immediate Impact
26 standout
Citing Papers
Endogenous stimuli-responsive separating microneedles to inhibit hypertrophic scar through remodeling the pathological microenvironment
2024 Standout
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
Works of Merete Krogh being referenced
TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial
2020
Single Institution Experience with S-1 (Teysuno) in Danish Patients with Gastro-Intestinal Cancer
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Merete Krogh | 189 | 68 | 30 | 41 | 17 | 222 | |
| Jietian Jin | 153 | 126 | 26 | 26 | 16 | 273 | |
| Keigo Chida | 131 | 58 | 21 | 53 | 17 | 183 | |
| Andrés Muñoz | 176 | 25 | 26 | 70 | 18 | 222 | |
| Paola Incollingo | 108 | 78 | 38 | 24 | 17 | 265 | |
| Rebecca Herbertson | 149 | 78 | 7 | 41 | 18 | 286 | |
| F. Espósito | 90 | 31 | 13 | 37 | 23 | 204 | |
| Maria Antista | 188 | 89 | 29 | 52 | 25 | 274 | |
| Michel Gatineau | 166 | 56 | 47 | 32 | 21 | 266 | |
| Estelle Cauchin | 126 | 62 | 39 | 85 | 19 | 225 | |
| Akimichi Imamura | 127 | 68 | 39 | 56 | 20 | 267 |
All Works
Login with ORCID to disown or claim papers
Loading papers...